Orencia abatacept drug market to reach $5.28 billion by 2030 at 6.1% cagr, driven by increasing prevalence of autoimmune diseases and rising personalized medicine.
Read More
Global Neuromyelitis Optica Spectrum Disorder market size is expected to reach $3.76 Billion by 2030 at 8.1%, rising multiple sclerosis cases fueling the growth of the market due to improved diagnostics and increased awareness
Read More
Orally disintegrating tablet market to reach $24.43 billion by 2030 at 8.5% cagr, driven by increasing incidence of neurological disorders.
Read More
The global Neurology Clinical Trials market size is expected to reach over $8.05 billion by 2030 at 6.7% CAGR, driven by the increasing prevalence of neurological disorders.
Read More
Oral vaccine market to reach $6.29 billion by 2030 at 9.7% cagr, driven by rising prevalence of infectious diseases.
Read More
Oral transmucosal drugs market to reach $63.76 billion by 2030 at 7.8% cagr, driven by rising incidence of parkinson’s disease.
Read More
The neurological disorder diagnostics market is set to reach $17.75 billion by 2030, growing at 7% CAGR, driven by AI-based neuroimaging, biomarkers, and precision neurology tools.
Read More
Oral solid dosage pharmaceutical formulation market to reach $846.38 billion by 2030 at 5.2% cagr, driven by increasing prevalence of chronic diseases.
Read More
Global Neurological Biomarkers market size is expected to reach $22.82 billion by 2030 at 14%, rising prevalence of neurological diseases fuels momentum in neurological biomarker market
Read More
Oral rehydration solution market to reach $6.92 billion by 2030 at 9.4% cagr, driven by increasing incidence of diarrheal diseases.
Read More